SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001385508-22-000044
Filing Date
2022-04-18
Accepted
2022-04-18 16:07:12
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A proxy_2022xfinal.htm DEF 14A 651924
  Complete submission text file 0001385508-22-000044.txt   653131
Mailing Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 464744124 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38193 | Film No.: 22832222
SIC: 2834 Pharmaceutical Preparations